Dr. Abhinav Gorukanti, CEO of Anthea Pharma Private Limited, holds a degree in Bachelor of Medicine and Bachelor of Surgery (MBBS) from Sri Ramachandra University in Chennai, India, and Masters of Business Administration (MBA) from IESE Business School, Spain. He is in the process of building a dynamic team of high-energy professionals to realize Anthea Pharma’s vision to be a global injectables CDMO firm.

He started out Anthea Pharma began with an niche focus of specializing in General Injectables manufacturing and targeting the regulated markets. Founded in 2019, this research-based business aims to produce high-quality molecules at an affordable cost.

Leading Yashoda Hospitals as one of the Directors and Head of International Services, that has a capacity of over 2400 beds, and an organization with close to 10,000 colleagues. It boasts of latest technology, techniques, and specialists required to perform complex procedures – deeming it world-class. He firmly believes that providing care with a personal human touch is important and has been involved in a lot of social projects, both in the medical and non-medical fields.

A Philanthropist – Driven by Humanitarian initiatives, Dr. Abhinav, also heads the Yashoda Foundation, which is dedicated to bridging the disparity in essential living that results from differences in access to and availability of resources for the unfortunate.

Dr. Abhinav Gorukanti
CEO of Anthea Pharma Private Limited